Abstract
The intravenous administration of the benzodiazepine inverse agonist DMCM (6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylic acid methyl ester) dose-dependently reduced the efficacy of electrical stimulation of the 5-HT pathway in depressing the firing activity of rat hippocampus pyramidal neurons. This effect was prevented by the benzodiazepine receptor antagonist flumazenil and reversed by the benzodiazepine receptor agonist diazepam. This indicates that DMCM alters 5-HT transmission in the rat dorsal hippocampus via benzodiazepine receptors and that these receptors have both agonist and inverse agonist sites.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
